INDIVIOR PLC(INDV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

INDV INDIVIOR PLC

Not Yet Opened 08-28 16:00:00 EDT

34.87

-0.43

-1.22%

盘后34.87

+0.000.00%

19:30 EDT

High35.49	Low34.49	Vol3.31M
Open35.31	D1 Closing35.30	Amplitude2.83%
Mkt Cap4.11B	Tradable Cap4.06B	Total Shares118.00M
T/O115.43M	T/O Rate2.84%	Tradable Shares116.45M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"INDV","market":"US","secType":"STK","nameCN":"INDIVIOR PLC","latestPrice":34.87,"timestamp":1787947200000,"preClose":35.3,"halted":0,"volume":3308672,"hourTrading":{"tag":"盘后","latestPrice":34.87,"preClose":34.87,"latestTime":"19:30 EDT","volume":1166020,"amount":40659116.02,"timestamp":1787959806047,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.012181303116147301,"floatShares":116454522,"shares":118000000,"eps":2.766067,"marketStatus":"Not Yet Opened","change":-0.43,"latestTime":"08-28 16:00:00 EDT","open":35.31,"high":35.49,"low":34.49,"amount":115432131.49401599,"amplitude":0.028329,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.766067,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":35.3,"preHourTrading":{"tag":"盘前","latestPrice":35.32,"preClose":35.3,"latestTime":"09:29 EDT","volume":873,"amount":30725.167779000003,"timestamp":1787923799999,"change":0.02,"changeRate":0.000567,"amplitude":0.078754},"postHourTrading":{"tag":"盘后","latestPrice":34.87,"preClose":34.87,"latestTime":"19:30 EDT","volume":1166020,"amount":40659116.02,"timestamp":1787959806047,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.9358076607015542,"impliedVol":0.3204,"impliedVolPercentile":0.06},"requestUrl":"/m/hq/s/INDV/wiki","defaultTab":"wiki","newsList":[{"id":"2661124492","title":"Indivior PLC Earnings Call: Merger, Margins and Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2661124492","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661124492?lang=en_us&edition=fundamental","pubTime":"2026-08-23 08:18","pubTimestamp":1787444320,"startTime":"0","endTime":"0","summary":"Indivior PLC (($INDV)) has held its Q2 earnings call. Read on for the main highlights of the call. Indivior PLC’s latest earnings call struck a not...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/indivior-plc-earnings-call-merger-margins-and-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/indivior-plc-earnings-call-merger-margins-and-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FEBU","INDV","DECU","JOYT","RGLO","PMDE","GXDW","VGFPF","BK4007","VOTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657949633","title":"Amylyx Pharmaceuticals Q2 Posts Higher than Expected Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2657949633","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657949633?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:26","pubTimestamp":1786015601,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals Q2 posts higher than expected lossOverviewBiopharma firm's Q2 net loss and loss per share missed analyst expectationsCompany completed final study visit in pivotal Phase 3 LUCID","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4430HM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMEA","MNKD","BK4584","BK4539","INDV","BK4585","BK4007","BK4139","AMLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657145503","title":"Top Indivior Executive Makes Bold New Stock Move","url":"https://stock-news.laohu8.com/highlight/detail?id=2657145503","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657145503?lang=en_us&edition=fundamental","pubTime":"2026-08-06 10:11","pubTimestamp":1785982294,"startTime":"0","endTime":"0","summary":"New insider activity at Indivior ( ($INDV) ) has taken place on August 5, 2026. Indivior’s Chief Administrative Officer, Woodrow D. Anderson, has s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-indivior-executive-makes-bold-new-stock-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-indivior-executive-makes-bold-new-stock-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657757548","title":"Indivior Chief Accounting Officer Woodrow D Anderson Acquires 1,500 Shares Worth $54,420","url":"https://stock-news.laohu8.com/highlight/detail?id=2657757548","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657757548?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:53","pubTimestamp":1785963183,"startTime":"0","endTime":"0","summary":"Indivior Chief Accounting Officer Woodrow D Anderson acquires 1,500 shares worth $54,420Indivior Chief Accounting Officer Woodrow D. Anderson bought 1,500 common shares in a market purchase at USD 36.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL9l7NNH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Indivior Chief Accounting Officer Woodrow D Anderson Acquires 1,500 Shares Worth $54,420","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657520648","title":"Vanda Pharmaceuticals Q2 Loss Widens on Lower Sales, Higher Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2657520648","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657520648?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:10","pubTimestamp":1785960629,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals Q2 loss widens on lower sales, higher costsOverviewU.S. biopharma firm's Q2 net product sales fell 4% yr/yr as HETLIOZ sales declinedFanapt Q2 net product sales rose 23% yr/yr, o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4421AD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","INDV","LU1571399168.USD","LPCN","BK4007","UTHR","VNDA","BK4139","LU1699723380.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657512077","title":"Indivior price target lowered to $43 from $46 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2657512077","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657512077?lang=en_us&edition=fundamental","pubTime":"2026-08-05 17:15","pubTimestamp":1785921336,"startTime":"0","endTime":"0","summary":"Barclays analyst Glen Santangelo lowered the firm’s price target on Indivior (INDV) to $43 from $46 and keeps an Overweight rating on the shares. T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/indivior-price-target-lowered-to-43-from-46-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/indivior-price-target-lowered-to-43-from-46-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657514639","title":"Barclays Reaffirms Their Buy Rating on Indivior (INDV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657514639","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657514639?lang=en_us&edition=fundamental","pubTime":"2026-08-05 16:36","pubTimestamp":1785918995,"startTime":"0","endTime":"0","summary":"Barclays analyst Glen Santangelo maintained a Buy rating on Indivior today and set a price target of $43.00. According to TipRanks, Santangelo is a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-reaffirms-their-buy-rating-on-indivior-indv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-reaffirms-their-buy-rating-on-indivior-indv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657598577","title":"Cumberland Pharmaceuticals Q2 Loss Widens After Apotex Transaction","url":"https://stock-news.laohu8.com/highlight/detail?id=2657598577","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657598577?lang=en_us&edition=fundamental","pubTime":"2026-08-05 06:33","pubTimestamp":1785882830,"startTime":"0","endTime":"0","summary":"Cumberland Pharmaceuticals Q2 loss widens after Apotex transactionOverviewUS biopharma firm's Q2 revenue from continuing operations fell after Apotex transaction reclassified branded business as disco","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL1N4411HO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LPCN","CPIX","INDV","PVLA","BK4007","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657569703","title":"Arrowhead Pharmaceuticals Q3 Revenue Jumps on Redemplo Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2657569703","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657569703?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:10","pubTimestamp":1785874254,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals Q3 revenue jumps on REDEMPLO growthOverviewRNAi therapeutics developer's fiscal Q3 revenue rose sharply, beating analyst expectationsCompany posted a wider net loss as operat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL1N44113H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDGL","BK4007","BK4588","BK4585","BK4139","ARWR","MEDI","INDV","RYTM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656655187","title":"Indivior price target raised to $53 from $50 at Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2656655187","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656655187?lang=en_us&edition=fundamental","pubTime":"2026-08-04 21:16","pubTimestamp":1785849381,"startTime":"0","endTime":"0","summary":"Craig-Hallum analyst Chase Knickerbocker raised the firm’s price target on Indivior (INDV) to $53 from $50 and keeps a Buy rating on the shares fol...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/indivior-price-target-raised-to-53-from-50-at-craig-hallum-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/indivior-price-target-raised-to-53-from-50-at-craig-hallum-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656555341","title":"Indivior Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2656555341","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656555341?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:01","pubTimestamp":1785844898,"startTime":"0","endTime":"0","summary":"Indivior Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings SummaryIndivior Pharmaceuticals IncINDV.OQreported quarterly adjusted earnings of $1.15 per share for the quarter ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N4411DR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656304910","title":"Switzerland's Crispr Therapeutics Q2 Casgevy Revenue Jumps 151%, Net Loss Narrows on FDA Approval for Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2656304910","media":"Reuters","labels":["productRelease","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656304910?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:26","pubTimestamp":1785788805,"startTime":"0","endTime":"0","summary":"Switzerland's CRISPR Therapeutics Q2 CASGEVY revenue jumps 151%, net loss narrows on FDA approval for expansionOverviewSwitzerland-U.S. gene-editing firm's Q2 CASGEVY revenue rose 151% yr/yr to $76 ml","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL1N440114:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","INDV","BK4007","TGTX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656304555","title":"Crinetics Q2 Revenue Jumps on Palsonify Launch, Withdraws Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2656304555","media":"Reuters","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656304555?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:22","pubTimestamp":1785788546,"startTime":"0","endTime":"0","summary":"Crinetics Q2 revenue jumps on PALSONIFY launch, withdraws guidanceOverviewU.S. endocrine drugmaker's Q2 revenue rose sharply on PALSONIFY launchCompany's Q2 net loss widened, while loss per share narr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL1N4400ZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRNX","BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656930664","title":"Germany's Fresenius Medical Q2 Revenue Beats; 2026 Outlook Reaffirmed","url":"https://stock-news.laohu8.com/highlight/detail?id=2656930664","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656930664?lang=en_us&edition=fundamental","pubTime":"2026-08-04 02:33","pubTimestamp":1785782036,"startTime":"0","endTime":"0","summary":"Germany's Fresenius Medical Q2 revenue beats; 2026 outlook reaffirmedOverviewGermany dialysis provider's Q2 revenue rose 1% yr/yr, beating analyst expectationsQ2 operating income grew 10% yr/yr; net i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL1N4400V1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656308800","title":"U.S. Stocks on the MOVE -Visa, Bowhead Specialty, Micron","url":"https://stock-news.laohu8.com/highlight/detail?id=2656308800","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656308800?lang=en_us&edition=fundamental","pubTime":"2026-08-03 23:43","pubTimestamp":1785771804,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE -Visa, Bowhead Specialty, MicronAugust 3 (Reuters)-Wall Street's main indexes opened higher on the first trading day of August as signs of de-escalating tensions in the Mi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL6N4400ZE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FANG","JGRO","PLOW","MU","GMEY","AZN.UK","CVX","SES","BABA","COHX","HYFM","ITGR","SO","LUV","ARES","ATKR","TTXU","BFLY","MGN","XOM","COHR","FICO","UAL","FSLR","AMC","MPWR","MAR","V","FDNI","BOW","688825","IR","COHC","ONLN","CNH","GUNZ","09988","ELPW","INDV","DAL","LNTH","BMY","AXON","AAL","APA","GME","SUPN","TSN","PCOR","PN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656148371","title":"Indivior and Supernus announce tax-free merger of equals","url":"https://stock-news.laohu8.com/highlight/detail?id=2656148371","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656148371?lang=en_us&edition=fundamental","pubTime":"2026-08-03 21:01","pubTimestamp":1785762109,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Indivior ( ($INDV) ). Indivior Pharmaceuticals, Inc. is a biopharmaceutical company focused on central nervous ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/indivior-and-supernus-announce-tax-free-merger-of-equals?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/indivior-and-supernus-announce-tax-free-merger-of-equals?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656667375","title":"Supernus, Indivior Merge to Strengthen Neuroscience Drug Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2656667375","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656667375?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:28","pubTimestamp":1785756539,"startTime":"0","endTime":"0","summary":"Supernus, Indivior merge to strengthen neuroscience drug portfolioAug 3 (Reuters)-Supernus PharmaceuticalsSUPN.Oand Indivior PharmaceuticalsINDV.Osaid on Monday they had agreed to an all-stock merger ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL4N4400WE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SUPN","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656373720","title":"TG Therapeutics Q2 Product Revenue Rises 70% on Briumvi Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2656373720","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656373720?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:13","pubTimestamp":1785755580,"startTime":"0","endTime":"0","summary":"TG Therapeutics Q2 product revenue rises 70% on BRIUMVI salesOverviewU.S. biotech's Q2 product revenue rose 70% yr/yr, driven by BRIUMVI salesQ2 net income and EPS declined from prior year as expenses","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL1N4400D6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","BK4532","BK4534","BK4568","TGTX","BK4588","BK4007","BK4551","TENX","LGHT","GNOM","INDV","BK4548","MRNX","BK4585","BK4533","BK4501","MRNY","MRNA","IDNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656437362","title":"Indivior Announces Merger Agreement to Acquire Supernus","url":"https://stock-news.laohu8.com/highlight/detail?id=2656437362","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656437362?lang=en_us&edition=fundamental","pubTime":"2026-08-03 18:58","pubTimestamp":1785754722,"startTime":"0","endTime":"0","summary":"Indivior ( ($INDV) ) just unveiled an announcement. On August 1, 2026, Indivior and Artemis Merger Sub entered into a merger agreement with Supernu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/indivior-announces-merger-agreement-to-acquire-supernus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/indivior-announces-merger-agreement-to-acquire-supernus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656015378","title":"Indivior Pharmaceuticals, Supernus Pharmaceuticals to Combine in All-Stock Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2656015378","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656015378?lang=en_us&edition=fundamental","pubTime":"2026-08-03 18:52","pubTimestamp":1785754357,"startTime":"0","endTime":"0","summary":"Indivior Pharmaceuticals, Supernus Pharmaceuticals to Combine in All-Stock Merger","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","SUPN","INDV"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.indivior.com","stockEarnings":[{"period":"1week","weight":-0.0542},{"period":"1month","weight":-0.1304},{"period":"3month","weight":-0.0319},{"period":"6month","weight":0.0657},{"period":"1year","weight":0.4602},{"period":"ytd","weight":-0.0281}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0547},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1215},{"period":"1year","weight":0.1856},{"period":"ytd","weight":0.1282}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet. The company operates in approximately 40 countries worldwide. It has collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.","yearOnYearQuotes":[{"month":1,"riseRate":0.583333,"avgChangeRate":0.021864},{"month":2,"riseRate":0.583333,"avgChangeRate":0.011788},{"month":3,"riseRate":0.416667,"avgChangeRate":-0.007447},{"month":4,"riseRate":0.833333,"avgChangeRate":0.037804},{"month":5,"riseRate":0.833333,"avgChangeRate":0.065087},{"month":6,"riseRate":0.5,"avgChangeRate":0.060391},{"month":7,"riseRate":0.727273,"avgChangeRate":0.153964},{"month":8,"riseRate":0.5,"avgChangeRate":-0.023886},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.095405},{"month":10,"riseRate":0.363636,"avgChangeRate":0.007009},{"month":11,"riseRate":0.545455,"avgChangeRate":0.010295},{"month":12,"riseRate":0.636364,"avgChangeRate":0.020229}],"exchange":"NASDAQ","name":"INDIVIOR PLC","nameEN":"INDIVIOR PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"INDIVIOR PLC(INDV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest INDIVIOR PLC(INDV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"INDIVIOR PLC,INDV,INDIVIOR PLC股票,INDIVIOR PLC股票老虎,INDIVIOR PLC股票老虎国际,INDIVIOR PLC行情,INDIVIOR PLC股票行情,INDIVIOR PLC股价,INDIVIOR PLC股市,INDIVIOR PLC股票价格,INDIVIOR PLC股票交易,INDIVIOR PLC股票购买,INDIVIOR PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"INDIVIOR PLC(INDV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest INDIVIOR PLC(INDV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction